Pancreatitis, Ozempic and exaggerated headlines: A UK alert raises concerns about drug abuse
The British drug agency is monitoring a possible increase in cases of the disease, although there is no data yet to warrant alarm
‘Obesity can kill’: Controversial campaign by Ozempic drugmaker sparks backlash
Novo Nordisk’s campaign, which aims to speak ‘without filters’ by declaring obesity a disease, has been strongly criticized on social media: ‘It’s indecent’
Hormone pellets, the ‘miracle’ anti-aging treatment under scrutiny
In a society increasingly reluctant to accept aging, scientific therapies aimed at combating it have found a growing market